Literature DB >> 26392629

Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome.

Isobel W Green1, Jill R Glausier2.   

Abstract

Schizophrenia is a clinically heterogeneous disorder that is perhaps more accurately characterized as "the schizophrenia syndrome." This clinical heterogeneity is reflected in the heterogeneous neurobiological presentations associated with the illness. Moreover, even highly specific neural aberrations that are associated with distinct symptoms of schizophrenia are linked to a wide range of risk factors. As such, any individual with schizophrenia likely has a particular set of risk factors that interact and converge to cross the disease threshold, forming a particular etiology that ultimately generates a core pathophysiology. This core pathophysiology may then produce 1 or more symptoms of schizophrenia, leading to common symptoms across individuals in spite of disparate etiologies. As such, the schizophrenia syndrome can be considered as anequifinalentity: a state of dysfunction that can arise from different upstream etiologies. Moreover, schizophrenia etiologies are multifactorial and can involve the interactive effects of a broad range of genetic, environmental, and developmental risk factors. Through a consideration of how disparate etiologies, caused by different sets of risk factors, converge on the same net dysfunction, this paper aims to model the equifinal nature of schizophrenia symptoms. To demonstrate the equifinal model, we discuss how maternal infection and adolescent cannabis use, 2 recognized schizophrenia risk factors, may interact with other genetic, environmental, and/or developmental risk factors to cause the conserved clinical presentation of impaired working memory.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  basket cell; cannabis; cholecystokinin; etiology; maternal infection; parvalbumin; prefrontal cortex; working memory

Mesh:

Year:  2015        PMID: 26392629      PMCID: PMC4838077          DOI: 10.1093/schbul/sbv136

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  108 in total

1.  Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response.

Authors:  Devon B Oskvig; Abdel G Elkahloun; Kory R Johnson; Terry M Phillips; Miles Herkenham
Journal:  Brain Behav Immun       Date:  2012-01-30       Impact factor: 7.217

Review 2.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

Review 3.  The neurodevelopmental hypothesis of schizophrenia: convergent clues from epidemiology and neuropathology.

Authors:  Michael Piper; Monica Beneyto; Thomas H J Burne; Darryl W Eyles; David A Lewis; John J McGrath
Journal:  Psychiatr Clin North Am       Date:  2012-07-15

4.  Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex.

Authors:  S M Eggan; D S Melchitzky; S R Sesack; K N Fish; D A Lewis
Journal:  Neuroscience       Date:  2010-06-11       Impact factor: 3.590

5.  A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia.

Authors:  A S Brown; P Cohen; J Harkavy-Friedman; V Babulas; D Malaspina; J M Gorman; E S Susser
Journal:  Biol Psychiatry       Date:  2001-03-15       Impact factor: 13.382

Review 6.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.

Authors:  Michael F Green
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

7.  Pharmacogenomics and personalized medicine in neuropsychiatry.

Authors:  Francis J McMahon; Thomas R Insel
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

Review 8.  Maternal infection and schizophrenia: implications for prevention.

Authors:  Alan S Brown; Paul H Patterson
Journal:  Schizophr Bull       Date:  2010-12-06       Impact factor: 9.306

Review 9.  Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

Authors:  Matthew Large; Swapnil Sharma; Michael T Compton; Tim Slade; Olav Nielssen
Journal:  Arch Gen Psychiatry       Date:  2011-02-07

Review 10.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

View more
  13 in total

Review 1.  Glial cells in schizophrenia: a unified hypothesis.

Authors:  Andrea G Dietz; Steven A Goldman; Maiken Nedergaard
Journal:  Lancet Psychiatry       Date:  2019-11-06       Impact factor: 27.083

2.  The relationship between fine particulate matter (PM2.5) and schizophrenia severity.

Authors:  Rika Eguchi; Daisuke Onozuka; Kouji Ikeda; Kenji Kuroda; Ichiro Ieiri; Akihito Hagihara
Journal:  Int Arch Occup Environ Health       Date:  2018-04-23       Impact factor: 3.015

Review 3.  The link between schizophrenia and substance use disorder: A unifying hypothesis.

Authors:  Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green
Journal:  Schizophr Res       Date:  2017-04-14       Impact factor: 4.939

4.  Categorical versus dimensional models of early psychosis.

Authors:  Peter Phalen; Zachary Millman; Pamela Rakhshan Rouhakhtar; Nicole Andorko; Gloria Reeves; Jason Schiffman
Journal:  Early Interv Psychiatry       Date:  2021-02-08       Impact factor: 2.732

5.  Altered Insular Function during Aberrant Salience Processing in Relation to the Severity of Psychotic Symptoms.

Authors:  Anna Walter; Claudia Suenderhauf; Renata Smieskova; Claudia Lenz; Fabienne Harrisberger; André Schmidt; Tobias Vogel; Undine E Lang; Anita Riecher-Rössler; Anne Eckert; Stefan Borgwardt
Journal:  Front Psychiatry       Date:  2016-11-23       Impact factor: 4.157

6.  Speed and capacity of working memory and executive function in schizophrenia compared to unipolar depression.

Authors:  Wolfgang Trapp; Simone Dotterweich; Lena Hintner; Hannah Wollny; Stefan Lautenbacher; Göran Hajak
Journal:  Schizophr Res Cogn       Date:  2017-07-28

7.  Experimental evidence for circular inference in schizophrenia.

Authors:  Renaud Jardri; Sandrine Duverne; Alexandra S Litvinova; Sophie Denève
Journal:  Nat Commun       Date:  2017-01-31       Impact factor: 14.919

Review 8.  Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.

Authors:  J A Lieberman; R R Girgis; G Brucato; H Moore; F Provenzano; L Kegeles; D Javitt; J Kantrowitz; M M Wall; C M Corcoran; S A Schobel; S A Small
Journal:  Mol Psychiatry       Date:  2018-01-09       Impact factor: 15.992

Review 9.  A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders.

Authors:  Shalini Singh; Yatan Pal Singh Balhara
Journal:  Indian J Med Res       Date:  2017-08       Impact factor: 2.375

10.  Association of Childhood Exposure to Nitrogen Dioxide and Polygenic Risk Score for Schizophrenia With the Risk of Developing Schizophrenia.

Authors:  Henriette Thisted Horsdal; Esben Agerbo; John Joseph McGrath; Bjarni Jóhann Vilhjálmsson; Sussie Antonsen; Ane Marie Closter; Allan Timmermann; Jakob Grove; Pearl L H Mok; Roger T Webb; Clive Eric Sabel; Ole Hertel; Torben Sigsgaard; Christian Erikstrup; David Michael Hougaard; Thomas Werge; Merete Nordentoft; Anders Dupont Børglum; Ole Mors; Preben Bo Mortensen; Jørgen Brandt; Camilla Geels; Carsten Bøcker Pedersen
Journal:  JAMA Netw Open       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.